Long-Term Analysis of DImethyl Fumarate, to Slow the Growth of Areas of Geographic Atrophy
Status:
Not yet recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
The primary objectives of the study are to assess the safety, tolerability and evidence of
activity of 12 months oral treatment with TEFIDERA® in subjects with Geographic Atrophy
associated with Age-Related Macular Degeneration (AMD).